Current status of measles in Japan: Molecular and seroepidemiological studies

Journal of Infection and Chemotherapy

Volumn 12, Issue 6, 2006, Pages 343-348

  Okafuji, Teruo ^a   Okafuji, Takao ^a   Fujino, Motoko ^b   Nakayama, Tetsuo ^b  

^a Okafuji Pediatric Clinic   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

Epidemiology; Genotypes; Measles; Vaccine

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

EPIDEMIC; GENOTYPE; HUMAN; IMMUNITY; IMMUNIZATION; JAPAN; MEASLES; MEASLES VIRUS; MOLECULAR EPIDEMIOLOGY; REVIEW; SERODIAGNOSIS; SEROLOGY; VIRUS STRAIN;

EID: 33846442075     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0490-7     Document Type: Review

References (29)

1. WHO 2002 WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide Wkly Epidemiol Rec 77 224 8
2. WHO. Progress in reducing global measles deaths: 1999-2004. Wkly Epidemiol Rec 2006;81:90-4
3. Strebel PM, Papania ML, Halsey NA. Measles vaccine. In Vaccines. Plotkin SA, Orenstein WA, editors. 4th edition. Philadelphia, Sounders. 2004;389-440
4. Rota PA RotaJS SB Redd SC Redd S Pattamadilok WJ Bellini 1998 Genetic analysis of measles viruses isolated in the United States, 1995-1996 J Infect Dis 177 204 8
5. PA Rota SL Liffick JS Rota RS Katz S Redd M Papania WJ Bellini 2002 Molecular epidemiology of measles viruses in the United States, 1997-2001 Emerg Infect Dis 8 902 8
6. HC Meissner PM Strebel WA Orenstein 2006 Measles vaccines and the potential for worldwide eradication of measles Pediatrics 114 1065 9
7. W Janaszek NJ Gay W Gut 2003 Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland Vaccine 21 473 8
8. National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division. Ministry of Health, Labour and Welfare 2006 The topic of this month: measles and rubella in Japan, as of March 2006 IASR 27 85 6
9. WHO 2005 New genotype of measles virus and update on global distribution of measles genotypes Wkly Epidemiol Rec 80 347 51
10. PA Rota SL Liffick JS Rota RS Katz S Redd M Papania 2002 Molecular epidemiology of measles viruses in the United States, 1997-2001 Emerg Infect Dis 8 902 8
11. T Nakayama T Mori S Yamaguchi S Sonoda S Asamura R Yamashita 1995 Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability Virus Research 35 1 16
12. S Yamaguchi 1997 Identification of three lineages of wild measles virus by nucleotide sequence analysis of N, P, M, F and L genes in Japan J Med Virol 52 113 20
13. T Nakayama M Fujino N Yoshida 2004 Molecular epidemiology of measles virus in Japan Pediatr Int 46 214 23
14. M Takahashi T Nakayama Y Kashiwagi T Takami S Sonoda T Yamanaka 2000 Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating J Med Virol 62 278 85
15. J Zhou M Fujino Y Inou A Kumada Y Aoki S Iwata 2003 H1 genotype of measles virus was detected in outbreaks in Japan after 2000 J Med Virol 70 642 8
16. K Mizuta C Abiko T Murata K Yamada T Ahiko M Sakamoto 2005 An outbreak of measles virus infection due to genotype D9 at a junior high school in Yamagata, Japan in 2004 Jpn J Infect Dis 58 98 100
17. D Chibo M Riddell M Catton M Lyon G Lum C Birch 2003 Studies of measles viruses circulating in Australia between 1999 and 2001 reveal a new genotype Virus Res 91 213 21
18. RL De Swart PME Wertheim-van Dillen RS van Binnendijk CP Muller J Frenkel ADME Osterhaus 2000 Measles in a Dutch hospital introduced by an immuno-compromised infant from Indonesia infected with a new virus genotype Lancet 355 201 2
19. LE Markowitz SR Preblud PEM Fine WA Orenstein 1990 Duration of live measles vaccine-induced immunity Pediatr Infect Dis J 9 101 10
20. CE Johnson ML Kumar JK Whitwell BO Staehle LP Rome C Dinakar 1996 Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at 4 to 6 vs 11 to 13 years Pediatr Infect Dis J 15 687 92
21. S van den Hof AB van Gageldonk-Lafeber RS van Binnendijk PGM van Gageldonk GAM Berbers 2003 Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralization assay Vaccine 21 4210 4
22. W Janaszek J Slusarczyk 2003 Immunity against measles in populations of women and infants in Poland Vaccine 21 2948 53
23. IR Pederson CH Mordhorst T Ewald H von Magnus 1986 Long-term antibody response after measles vaccination in an isolated arctic society in Greenland Vaccine 4 173 8
24. J Mossong CJ O'Callaghan S Ratnam 2001 Modeling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population Vaccine 19 523 9
25. I Davidkin M Valle 1998 Vaccine-induced measles virus antibodies after two doses of combined measles, mumps, and rubella vaccine: a 12-year follow-up in two cohorts Vaccine 16 2052 7
26. MS Lee LJ Chien YY Yueh CF Lu 2001 Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995-1997 Vaccine 19 4644 51
27. S Krugman 1983 Further-attenuated measles vaccine: characteristics and use Rev Infect Dis 5 477 81
28. S Sonoda T Nakayama 2001 Detection of measles virus genome in lymphocytes from asymptomatic healthy children J Med Virol 65 381 7
29. S Sonoda M Kitahara T Nakayama 2002 Detection of measles virus genome in bone-marrow aspirates from adults J Gen Virol 83 2485 8